Trial Profile
Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Oct 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 10 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 15 Apr 2015 Planned End Date changed from 1 Dec 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov
- 15 Apr 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov